HSF2 Activators

HSF2 activators encompass a range of chemicals that indirectly influence the activity of Heat Shock Factor 2, primarily through the modulation of cellular stress responses and heat shock protein (HSP) expression. These activators include molecules that interact with molecular chaperones like Hsp90, proteasome inhibitors, and compounds that induce oxidative or proteotoxic stress, thereby activating cellular defense mechanisms that can include HSF2-mediated pathways.

Molecules like Celastrol, 17-AAG, and Geldanamycin function by either binding to and inhibiting Hsp90, a crucial chaperone protein, or by inducing a general heat shock response. The inhibition of Hsp90 leads to an increased expression of heat shock proteins, which are under the regulatory control of factors like HSF2. This upregulation is a part of the cell's response to proteotoxic stress. Proteasome inhibitors such as MG132 and Bortezomib work by disrupting the degradation pathway of misfolded proteins, leading to an accumulation of these proteins and activation of stress response pathways, including those regulated by HSF2. Furthermore, compounds like Quercetin, Zinc Pyrithione, and Geranylgeranylacetone induce the expression of heat shock proteins by different mechanisms, ranging from direct transcriptional activation to stabilization of these proteins. Arimoclomol and Elesclomol represent a class of drugs that induce cellular stress responses, like oxidative stress, triggering a cascade of events that can lead to HSF2 activation.